There have been reports of skin rash developing in patients with COVID‐19 on favipiravir therapy, including a recent report in this journal. We report a patient who developed a maculopapular… Click to show full abstract
There have been reports of skin rash developing in patients with COVID‐19 on favipiravir therapy, including a recent report in this journal. We report a patient who developed a maculopapular skin rash while taking favipiravir.
               
Click one of the above tabs to view related content.